CHINOOK THERAPEUTICS INC's ticker is KDNY and the CUSIP is 16961L106. A total of 89 filers reported holding CHINOOK THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $31,045,127 | +2453.4% | 808,046 | +1438.5% | 0.01% | +1200.0% |
| Q1 2023 | $1,215,838 | -11.6% | 52,520 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $1,376,024 | +99.4% | 52,520 | +49.5% | 0.00% | – |
| Q3 2022 | $690,000 | +12.4% | 35,120 | 0.0% | 0.00% | – |
| Q2 2022 | $614,000 | +11.0% | 35,120 | +3.8% | 0.00% | – |
| Q1 2022 | $553,000 | +0.5% | 33,820 | +0.3% | 0.00% | – |
| Q4 2021 | $550,000 | +36.5% | 33,720 | +6.6% | 0.00% | – |
| Q3 2021 | $403,000 | -9.6% | 31,620 | 0.0% | 0.00% | – |
| Q2 2021 | $446,000 | +18.6% | 31,620 | +30.6% | 0.00% | – |
| Q1 2021 | $376,000 | -2.1% | 24,220 | 0.0% | 0.00% | – |
| Q4 2020 | $384,000 | – | 24,220 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 5,161,888 | $119,497,707 | 24.70% |
| Saturn V Capital Management LP | 506,818 | $11,732,837 | 8.76% |
| Octagon Capital Advisors LP | 2,551,703 | $59,071,924 | 8.50% |
| Affinity Asset Advisors, LLC | 976,021 | $22,594,886 | 7.46% |
| Frazier Life Sciences Management, L.P. | 4,345,559 | $100,599,691 | 7.28% |
| Altium Capital Management LP | 305,000 | $7,060,750 | 3.92% |
| Deep Track Capital, LP | 3,000,000 | $69,450,000 | 2.85% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 319,989 | $7,407,745 | 2.07% |
| Nan Fung Group Holdings Ltd | 113,950 | $2,637,943 | 1.80% |
| Nicholas Investment Partners, LP | 972,191 | $22,506,222 | 1.71% |